Which hedge funds own ARCT? ARCTURUS THERAPEUTICS HLDGS, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in ARCT (ARCTURUS THERAPEUTICS HLDGS) in their Q2 2026 13F filings, worth $7.6m in total. The largest holder by portfolio weight is Brevan Howard Capital Management at 0.0% of its book. 1 manager opened a new position this quarter: Marshall Wace.
7tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold ARCT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $193.3k | 28,762 | -12% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $1.6m | 231,582 | 263% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.6m | 392,358 | 56% | added |
| Millennium Management | Q2 2026 | 0.0% | $2.3m | 336,996 | -30% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $519.2k | 77,269 | – | new |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $143.8k | 21,400 | -88% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $275.2k | 40,946 | 18% | added |
How has hedge fund ownership of ARCT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $7.6m |
| Q1 2026 | 6 | $8.0m |
| Q4 2025 | 3 | $2.5m |
| Q3 2025 | 1 | $1.2m |
| Q2 2025 | 2 | $10.2m |
| Q1 2025 | 2 | $8.4m |
| Q4 2024 | 1 | $13.7m |
| Q3 2024 | 1 | $18.1m |
| Q2 2024 | 2 | $24.3m |
| Q1 2024 | 3 | $42.4m |
| Q4 2023 | 3 | $34.6m |
| Q3 2023 | 3 | $40.5m |
| Q2 2023 | 3 | $38.4m |
| Q1 2023 | 2 | $21.5m |
| Q4 2022 | 2 | $13.9m |
| Q3 2022 | 3 | $22.2m |
Counts every tracked manager that disclosed ARCT in that quarter's filing, including managers that have since stopped filing.